Inteliview
Log inSign up
Topics

Altria Q1 2026: Adjusted EPS of $1.32 Beats Expectations

Altria Group reported Q1 2026 net revenues of $5.43 billion, up 3.2% year-over-year, with adjusted EPS of $1.32 exceeding consensus by $0.07. The company reaffirmed full-year adjusted EPS guidance of $5.56–$5.72.

전영빈··6 min read
한국어로도 볼 수 있습니다한국어로 보기 →
Altria Q1 2026: Adjusted EPS of $1.32 Beats Expectations
Altria Q1 2026: Adjusted EPS of $1.32 Beats Expectations
AIKey Summary
  • Altria posted Q1 2026 adjusted EPS of $1.32, beating estimates by $0.07 on $5.43B revenue growth
  • The company reaffirmed full-year EPS guidance of $5.56–$5.72, up 2.5–5.5% from 2025
{"time":1777550412401,"blocks":[{"type":"paragraph","data":{"text":"Altria Group reported Q1 2026 adjusted earnings per share (EPS) of $1.32, exceeding consensus estimates by $0.07, according to an SEC 8-K filing dated April 30, 2026."}},{"type":"delimiter","data":{}},{"type":"header","data":{"text":"Q1 2026 Results at a Glance","level":2}},{"type":"paragraph","data":{"text":"Altria's Q1 net revenues reached $5.43 billion, up 3.2% year-over-year, driven primarily by growth in the cigarette segment. Excise tax-adjusted net revenues climbed to $4.76 billion, a 5.3% increase. Adjusted EPS grew 7.3% to $1.32 from $1.23 in the prior-year quarter. GAAP diluted EPS surged to $1.30 versus $0.63 in Q1 2025, more than doubling year-over-year. This spike reflects the favorable base effect from a $873 million non-cash goodwill impairment charge on the e-vapor segment recorded in the prior-year period."}},{"type":"list","data":{"style":"unordered","items":["Net revenues: $5.43 billion, +3.2% YoY","Excise tax-adjusted net revenues: $4.76 billion, +5.3% YoY","Adjusted EPS: $1.32, beating consensus of $1.25 by $0.07","GAAP diluted EPS: $1.30 vs. $0.63 prior year, >100% increase","Q1 share repurchases: $280 million for 4.5 million shares at average price of $62.33 per share","Q1 dividends paid: $1.8 billion"]}},{"type":"delimiter","data":{}},{"type":"header","data":{"text":"Full-Year 2026 Outlook","level":2}},{"type":"paragraph","data":{"text":"Altria reaffirmed its 2026 full-year adjusted EPS guidance of $5.56–$5.72, representing 2.5–5.5% growth versus the 2025 baseline of $5.42. CEO Billy Gifford stated, "Given the strength of our Q1 results, we expect EPS growth to be more evenly distributed between the first and second halves of 2026." The company's outlook accounts for slowing e-vapor market growth and macroeconomic uncertainty. The company assumes NJOY ACE will not return to the U.S. market during 2026."}},{"type":"delimiter","data":{}},{"type":"header","data":{"text":"Market Reaction","level":2}},{"type":"paragraph","data":{"text":"Reuters reported that Altria exceeded quarterly earnings expectations. Street Insider noted the adjusted EPS beat consensus by $0.07. GuruFocus highlighted ongoing valuation discussions following the beat. Specific post-announcement stock price movements were not disclosed in the official filings or news reports."}},{"type":"delimiter","data":{}},{"type":"header","data":{"text":"Segment Performance","level":2}},{"type":"list","data":{"style":"unordered","items":["Smokeable products (cigarettes): Net revenue growth drove overall results, according to company filings. Segment-specific revenue figures not disclosed.","Oral tobacco products: The on! brand performed competitively in a challenging market. on! PLUS expanded to national distribution. Segment-specific revenue figures not disclosed.","E-vapor products (NJOY): NJOY ACE faces an import ban and sales suspension order from the U.S. International Trade Commission (ITC), preventing market return through 2026. Segment-specific revenue figures not disclosed."]}},{"id":"disclaimer-d","type":"delimiter","data":{}},{"id":"disclaimer-p","type":"paragraph","data":{"text":"This article was auto-generated from the SEC 8-K filing and third-party news reports to deliver key earnings data promptly. Investors are advised to review official company filings before making trading decisions."}}],"version":"2.28.2"}
MOMO
Loading...

Frequently Asked Questions

Why does Altria's adjusted EPS differ from GAAP EPS?

GAAP EPS is calculated using standard accounting principles, while adjusted EPS excludes one-time charges such as goodwill impairments and litigation costs. In Q1 2026, adjusted EPS was $1.32 versus GAAP EPS of $1.30. In Q1 2025, a $873 million non-cash e-vapor goodwill impairment depressed GAAP EPS to $0.63, highlighting the significance of excluding such items for operational comparison.

Why can't Altria sell NJOY ACE?

The U.S. International Trade Commission (ITC) issued an import ban and sales suspension order for NJOY ACE products. Altria does not expect the product to return to the U.S. market during 2026.

How much did Altria return to shareholders in Q1?

The company paid $1.8 billion in dividends during Q1. Additionally, it repurchased 4.5 million shares for $280 million at an average price of $62.33 per share. Altria has $720 million remaining under its $2 billion share repurchase authorization, which expires December 31, 2026.

What is Altria's full-year 2026 earnings outlook?

Altria projects 2026 full-year adjusted EPS of $5.56–$5.72, representing 2.5–5.5% growth versus 2025's baseline of $5.42 per share. This guidance incorporates slowing e-vapor market growth and macroeconomic headwinds.

More on this topic
전영빈
Author

전영빈

Topics
FREE MEMBERSHIP

Did you find this useful?

Sign up to bookmark articles, follow gurus, and manage your portfolio — all for free.

Guru trade alerts
Portfolio tracker
Article bookmarks

Related Articles

Insights

INTELIVIEW NEWSLETTER

Smart Money Briefing

Weekly summaries of Wall Street guru moves and crypto whale activity.